NCT04132128 is a NA clinical trial of carbohydrate counting in Diabetes Mellitus, sponsored by Soroka University Medical Center.

Who is sponsoring NCT04132128?

NCT04132128 is sponsored by Soroka University Medical Center.

What drugs are being tested in NCT04132128?

Interventions in NCT04132128: carbohydrate counting.

What condition does NCT04132128 study?

NCT04132128 studies Diabetes Mellitus, Carbohydrates, Insulin Sensitivity, HbA1C.

Is NCT04132128 still recruiting?

NCT04132128 is currently completed. Last updated 11 May 2023.

Last reviewed 2023-05-11 · How we verify

NCT04132128

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SUCCEED - Soroka Utility for Counting Carbs Easily and Effectively for Diabetes

Completed NA Last updated 11 May 2023

What this trial tests

NA trial testing carbohydrate counting in Diabetes Mellitus in 107 participants. Completed in 5 August 2019.

Timeline

25 November 2015

Primary endpoint
28 February 2018

5 August 2019

Quick facts

Lead sponsor	Soroka University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	107
Start date	25 November 2015
Primary completion	28 February 2018
Estimated completion	5 August 2019

Drugs / interventions tested

carbohydrate counting

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →
Carbohydrates — all drugs for Carbohydrates →
Insulin Sensitivity — all drugs for Insulin Sensitivity →
HbA1C — all drugs for HbA1C →

Sponsor

Soroka University Medical Center

Who can join

18 and older, any sex, with Diabetes Mellitus or Carbohydrates. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Counting Carbohydrates (CC) is the preferable method used to calculate the amount of insulin needed for a meal. This method is employed by patients with type 1 diabetes melitus (T1DM). the patients receive the general arithmetic calculation of how much insulin to inject for 15 grams/1 portion of carbohydrate (carb to insulin ratio (C:I) and insulin sensitivity (IS). However, Diabetes Educators are often confronted with difficulties guiding their T1DM patient when using this method and find patients get confused calculating the amount of carbs needed. The investigators sought to create a simple tool that would help our patients implement the CC method easily and properly.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Simplifying carb counting: A randomized controlled study - Feasibility and efficacy of an individualized, simple, patient-centred carb counting tool.
Witkow S, Liberty IF, Goloub I, Kaminsky M, et al · · 2023 · cited 11× · PMID 36750449 · DOI 10.1002/edm2.411

Verify or expand the search:

Other trials of carbohydrate counting

Trials testing the same drug.

NCT02350374 — Carbohydrate Counting in Children and Adolescents With Type 1 Diabetes · NA · completed

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other Soroka University Medical Center trials

Trials by the same sponsor.

NCT06583967 — The Effect of Aerobic Exercise on an Elliptical Trainer Versus a Treadmill, in People With Multiple Sclerosis · NA · completed
NCT05502913 — Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer · Phase 2 · recruiting
NCT06251271 — Diagnosing Obstructive Lung Disease With Point of Care Ultrasound · completed
NCT06221254 — A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease · NA · recruiting
NCT05230602 — Consuming of Opuntia Among Women With Fibromyalgia · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04132128 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Soroka University Medical Center
Last refreshed: 11 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04132128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing